GL1X · GenesisL1 explorer

MolNFT v1 · #57025 · protein

Crystal structure of the human rxr alpha ligand binding domain bound to a synthetic agonist compound and a coactivator peptide

2ZXZ · Retinoic acid receptor rxr-alpha: “Crystal structure of the human rxr alpha ligand binding domain bound to a synthetic agonist compound and a…”. X-ray diffraction, 1 ligand (P26), 3 pockets (best druggability 0.84). MolNFT v1 #57025…

PDB
2ZXZ
Type
protein
Length
224 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Retinoic acid receptor rxr-alpha; GRIP1 from nuclear receptor coactivator 2
UniProt
P19793, Q15596
Ligands
P26
Pockets
3 · best druggability 0.84

Structure

x-ray diffraction · 2 distinct chains · 67% helix, 3% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARetinoic acid receptor rxr-alphaprotein21368% helix, 3% strandP19793
BGRIP1 from nuclear receptor coactivator 2protein1155% helix, 0% strandQ15596

Ligands and binding sites

  • P26 · 4-[2-(1,1,3,3-tetramethyl-2,3-dihydro-1H-inden-5-yl)-1,3-dioxolan-2-yl]benzoic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12140.840.9733P26
2700.500.8411empty
31300.400.7421empty

Interfaces

1 interface between chains.

  • A–B · 574 Ų buried · 5 hydrogen bonds · protein-protein

Compared structures

  • 2ZXZ · Crystal structure of the human RXR alpha ligand binding domain bound to a synthetic… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.